Results

Total Results: 460 records

Showing results for "vascular".

121. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
     February 01, 2008 - Boston Scientific Corporation Summary unavailable Simon Nitinol Filter™ System Bard Peripheral Vascular … embolism from migrating to the pulmonary arteries Eclipse™ Vena Cava Filter Bard Peripheral Vascular … where anticoagulant therapy has failed or is contraindicated G2X® Filter System Bard Peripheral Vascular … anticoagulant therapy has failed or is contraindicated Recovery® G2® Filter System Bard Peripheral Vascular

122. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
     February 01, 2008 - Boston Scientific Corporation Summary unavailable Simon Nitinol Filter™ System Bard Peripheral Vascular … embolism from migrating to the pulmonary arteries Eclipse™ Vena Cava Filter Bard Peripheral Vascular … where anticoagulant therapy has failed or is contraindicated G2X® Filter System Bard Peripheral Vascular … anticoagulant therapy has failed or is contraindicated Recovery® G2® Filter System Bard Peripheral Vascular

123. Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/antiplatelet-treatment/research
     September 25, 2013 - Current Page Topic Timeline Aug. 4, 2010 Topic Suggestion Nov. 22, 2011 Research Protocol Sep. 25, 2013 Systematic Review Feb. 13, 2014 Disposition of Comments Report Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment Systematic Review Archived September 25, 2013 Web Version [NL…

124. Treatment Strategies for Patients With Peripheral Artery Disease (PAD) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/peripheral-artery-disease-treatment/research-protocol/

125. Comparative Effectiveness of Adjunctive Devices to Remove Thrombi or Protect Against Distal Embolization in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention of Native Vessels | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/acs-pci-adjunctive-devices/research-protocol
     July 01, 2010 - Current Page Topic Timeline Jun. 19, 2008 Topic Suggestion Jul. 1, 2010 Research Protocol Dec. 29, 2011 Systematic Review May. 2, 2012 Disposition of Comments Report Jun. 25, 2013 Surveillance Report Comparative Effectiveness of Adjunctive Devices to Remove Thrombi or Protect Against Distal Embolization in Patients w…

126. Adjunctive Devices for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/acs-pci-adjunctive-devices/research
     December 29, 2011 - Current Page Topic Timeline Jun. 19, 2008 Topic Suggestion Jul. 1, 2010 Research Protocol Dec. 29, 2011 Systematic Review May. 2, 2012 Disposition of Comments Report Jun. 25, 2013 Surveillance Report Adjunctive Devices for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Systemati…

127. Evaluating the Effects of Drug-Eluting and Bare Metal Stents in Patient Subgroups and Comparing Diagnostic Tools in Predicting Outcomes Following Stenting Procedures | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/coronary-stents-effects/abstract
     December 15, 2009 - Evaluating the Effects of Drug-Eluting and Bare Metal Stents in Patient Subgroups and Comparing Diagnostic Tools in Predicting Outcomes Following Stenting Procedures Research Report December 15, 2009 Findings from this study were published in the following journal articles. Tsai TT, Messenger JC, Bren…

128. Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/clinician
     July 25, 2017 - Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence Clinician Summary Archived July 25, 2017 Download Main Document PDF 250 KB Archived: This report is greater than 3 years old. Findings may be used for research purposes, but should not be considered current.   Focus of Th…

129. Searching for Relevant Studies (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/searching.ppt
     January 01, 2011 - ischemia/ Angina Pectoris/ or Angina, unstable/ Angina Pectoris/ or Arterial occlusive disease/ Peripheral vascular … diseases/ Vascular diseases/ Atherosclerosis/ Cardiovascular diseases/ Carotid artery diseases/ ((( … (normal adj lvef) or (normal adj ef)).mp 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 Terms for vascular … to humans .sh = subheading All headings for ACE inhibitors and ARBs including free text (.mp) All vascular … Finally, we combine lines 11, 21, and 27 by using the “and” operator, which allows us to search for all vascular

130. Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/venous-ulcers-treatment/research-protocol
     March 05, 2012 - As a general rule, Duplex scanning, which is now considered routine in most vascular laboratories, is … from trauma in patients without signs of previous venous disease; ulcers in the setting of collagen vascular … from trauma in patients without signs of previous venous disease; ulcers in the setting of collagen vascular

131. Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non–ST Elevation Myocardial Infarction | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/angina-heart-attack-treatments/research
     November 04, 2013 - Current Page Topic Timeline Oct. 25, 2011 Topic Initiated Dec. 13, 2012 Research Protocol Nov. 4, 2013 Systematic Review Feb. 13, 2014 Disposition of Comments Report Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non–ST Elevation Myocardial Infarction Systematic Review Archived November 4, 2013 Web …

132. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/ace-inhibitor-arb-future/research

133. Data Points #8: Utilization of antihypertensive drug classes among Medicare beneficiaries with hypertension, 2007 to 2009 | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/hypertension-drugs-utilization/research
     November 16, 2011 - Data Points #8: Utilization of antihypertensive drug classes among Medicare beneficiaries with hypertension, 2007 to 2009 Research Report November 16, 2011 Web Version [NLM Site] Download Main Document PDF 1.3 MB People using assistive technology may not be able to fully access information in these file…

134. Assessing the Impact of AHRQ Evidence-based Practice Center (EPC) Reports on Future Research | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/methods-future-research-impact/research

135. Birthmarks | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/birthmarks
     June 21, 2016 - Treating Infantile Hemangiomas in Children Consumer Summary Archived June 21, 2016 Tratamiento del hemangioma infantil en niños Consumer Summary Archived March 16, 2017 Technical Brief: Evaluation of Suspicious Skin Lesions Using Non-Invasive Diagnostic Techniques Resea…

136. Dietary-Supplements Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
     April 01, 2012 - serum markers Dietary supplements Pharmacokinetic Outcomes Clinical Outcomes Mortality Peripheral vascular … outcomes for grading the strength of evidence Key Question Outcomes 1 Mortality (all-cause and vascular … to daily aspirin on the composite outcome of nonfatal myocardial infarction, nonfatal stroke, and vascular … death; evidence on individual vascular events was not available. … effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular

137. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ischemic-stroke-treatment_executive.pdf
     January 01, 2011 - In-Time Boston Scientific Retrieval of intravascular foreign objects in peripheral No longer vascular … N/A No longer marketed LaTIS Spectranetics Removal of thrombus from vascular grafts No longer marketed

138. Clopidogrel After Drug-Eluting Stent Implantation: Is Current Practice Sufficient? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/stent-clopidogrel-practice/research
     March 31, 2009 - valvular heart disease, third heart sound, history of cerebrovascular disease, history of peripheral vascular

139. Comparative Effectiveness of β-Adrenergic Antagonists on the Risk of Rehospitalization in Adults with Heart Failure (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-rehospitalization_research.pdf
     November 01, 2007 - arteries) PAD ICD9P 39 Other operations on vessels (code incomplete) PAD ICD9P 39.2 Other shunt or vascular … Aorta-renal bypass PAD ICD9P 39.25 Aorta-iliac-femoral bypass PAD ICD9P 39.26 Other intra-abdominal vascular … disease- claudication intermittent PAD OSCR 4439.001 PVD/Peripheral Vascular Disease (1994, 1995 listed … vascular disease- claudication PAD OSCR 4439.006 PVD; Chest Pain PAD OSCR 4439.900 PVD PAD CPT4 … etiology undetermined DEMENT OSCR 29040.001 Dementia multi-infarct DEMENT OSCR 29040.002 Dementia vascular

140. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
     September 13, 2012 - As a general rule, Duplex scanning, which is now considered routine in most vascular laboratories, is … from trauma in patients without signs of previous venous disease; ulcers in the setting of collagen vascular … from trauma in patients without signs of previous venous disease; ulcers in the setting of collagen vascular